Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Izrael

8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  Where

  Haifa, Jerusalem, Tel Aviv, Tiberias

  Életkor

  18 év and over

  People

  1046 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06717347 · EU 2024-515566-13-00
• 1/2. fázisTaking people
  Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

  Where

  Haifa, Jerusalem, Petah Tikva, Tel Aviv

  Életkor

  18 év and over

  People

  180 worldwide

  Run by

  ModeX Therapeutics, An OPKO Health Company

  See details and how to joinNCT07249905
• 3. fázisTaking people
  A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  Where

  Ashdod, Haifa, Jerusalem, Nahariya, Tel Aviv, Tel-Hashomer

  Életkor

  18 év and over

  People

  904 worldwide

  Run by

  Regeneron Pharmaceuticals

  See details and how to joinNCT06091865 · EU 2022-502785-25-00
• 2/3. fázisTaking people
  A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

  Where

  Afula, Haifa, Jerusalem

  Életkor

  18 év and over

  People

  290 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT05139017 · EU 2022-502646-27-00
• 2. fázisTaking people
  A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

  Where

  Beersheba, Haifa, Holon, Jerusalem, Petah Tikva, Ramat Gan, Safed, Tel Aviv

  Életkor

  18 év and over

  People

  594 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06890884 · EU 2024-515526-89-00
• 1/2. fázisTaking people
  Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  Where

  Haifa, Ramat Gan

  Életkor

  6 hónap to 25 év

  People

  90 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06395103 · EU 2023-507178-41-00
• No phaseTaking people
  Early Detection and Screening of Hematological Malignancies - SANGUINE

  Where

  Tel Aviv

  Életkor

  18 év and over

  People

  3000 worldwide

  Run by

  JaxBio Ltd

  See details and how to joinNCT05735704
• No phaseTaking people
  Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

  Where

  Jerusalem, Petah Tikva, Tel Aviv

  Életkor

  18 év and over

  People

  700 worldwide

  Run by

  AbbVie

  See details and how to joinNCT06830759